0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å
Ønsker du salgsvekst?
B2B Connect er en plattform hvor bedrifter som trenger salgsmøter kan benytte seg av så mange profesjonelle møtebookere de ønsker, fra en stor pool.
Du betaler kun per booket (og gjennomført) salgsmøte, og pris per salgsmøte bestemmer du selv. Det er ingen bindinger, og ingen oppstarts- eller abonnementsavgift. Prøve oss med kun 3 møter?
Navn | Norinnova Invest AS |
---|---|
Orgnr/født år | 991080961 |
Ant aksjer | 44,650 |
Omsetning | 0 |
Driftsresultat | -327 |
Egenkapital | -67,371 |
Ant.eiere | 28 |
Navn | Orgnr/født år | Aksjeklasse | Ant aksjer | Andel |
---|---|---|---|---|
Norinnova AS | 957915035 | A-aksjer | 8,217 | 18.4% |
Formue Private Equity AS | 979912986 | A-aksjer | 6,162 | 13.8% |
Equinor Ventures AS | 980516229 | A-aksjer | 4,111 | 9.2% |
Origo Kapital AS | 980928276 | A-aksjer | 3,288 | 7.4% |
Sparebank 1 Nord-Norge Portefølje AS | 935491533 | A-aksjer | 3,288 | 7.4% |
Troms Kraft AS | 979468792 | A-aksjer | 3,288 | 7.4% |
Dnb Bank ASA | 984851006 | A-aksjer | 2,465 | 5.5% |
Statkraft AS | 987059699 | A-aksjer | 2,260 | 5.1% |
Norinnova Forvaltning AS | 991381473 | A-aksjer | 1,641 | 3.7% |
Gjensidige Forsikring ASA | 995568217 | A-aksjer | 1,641 | 3.7% |
Kongsberg Gruppen ASA | 943753709 | A-aksjer | 1,233 | 2.8% |
Norinnova Forvaltning AS | 991381473 | B-aksjer | 1,166 | 2.6% |
Norinnova AS | 957915035 | B-aksjer | 829 | 1.9% |
Marinvest AS | 980264033 | A-aksjer | 823 | 1.8% |
Sparebanken Narvik | 937903979 | A-aksjer | 823 | 1.8% |
Formue Private Equity AS | 979912986 | B-aksjer | 621 | 1.4% |
Equinor Ventures AS | 980516229 | B-aksjer | 414 | 0.9% |
Narvik Kapital AS | 987416874 | A-aksjer | 410 | 0.9% |
Sparebank 1 Nord-Norge Portefølje AS | 935491533 | B-aksjer | 332 | 0.7% |
Troms Kraft AS | 979468792 | B-aksjer | 332 | 0.7% |
Origo Kapital AS | 980928276 | B-aksjer | 332 | 0.7% |
Dnb Bank ASA | 984851006 | B-aksjer | 249 | 0.6% |
Statkraft AS | 987059699 | B-aksjer | 228 | 0.5% |
Gjensidige Forsikring ASA | 995568217 | B-aksjer | 166 | 0.4% |
Kongsberg Gruppen ASA | 943753709 | B-aksjer | 124 | 0.3% |
Marinvest AS | 980264033 | B-aksjer | 83 | 0.2% |
Sparebanken Narvik | 937903979 | B-aksjer | 83 | 0.2% |
Narvik Kapital AS | 987416874 | B-aksjer | 41 | 0.1% |
Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
---|---|---|---|---|---|---|
Prophylix Pharma Holding AS | 65,894 | 10.8% | -7 | 2,120 | 40 | |
Calanus AS | 1,915,009 | 9.1% | 5,102 | -3,610 | 13,706 | 60 |
Prophylix Pharma Holding AS | 55,388 | 9.1% | -6 | 1,782 | 40 | |
Vitux Group AS | 3,416,636 | 8.7% | 1,399 | 252 | 18,760 | 36 |
Prophylix Pharma Holding AS | 35,394 | 5.8% | -4 | 1,139 | 40 | |
Prophylix Pharma Holding AS | 34,871 | 5.7% | -4 | 1,122 | 40 | |
Lyfstone AS | 467,289 | 2.9% | 29 | -9 | -26 | 116 |
Lytix Biopharma AS | 557,510 | 1.4% | 56 | -1,347 | 714 | 1,097 |
Amicoat AS | 264,023 | 0.9% | 154 | -40 | 486 | 311 |
Pharmasum Therapeutics AS | 23,362 | 0.7% | 10 | -11 | 21 | 683 |
Lyfstone Invest AS | 20,000 | 0.7% | 0 | -0 | 99 | 29 |
Pharma Holdings AS | 4,950 | 0.5% | 9 | -74 | 80 | 291 |
* Justert for eierandel
Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
---|---|---|---|---|---|---|
Prophylix AS | 0 | 10.8% | -33 | -1,384 | 1 | |
Zooca Calanus AS
Via Calanus AS |
2,738 | 9.1% | -1 | 2 | 1 | |
Salgard AS
Via Calanus AS |
624 | 9.1% | 25 | 14 | 47 | 1 |
Prophylix AS | 0 | 9.1% | -28 | -1,163 | 1 | |
Vitux Pharma AS
Via Vitux Group AS |
2,123 | 8.7% | -5 | 137 | 1 | |
Vitux AS
Via Vitux Group AS |
128 | 8.7% | 22,648 | 1,687 | 11,623 | 1 |
Prophylix AS | 0 | 5.8% | -18 | -743 | 1 | |
Prophylix AS | 0 | 5.7% | -18 | -732 | 1 | |
Peptide Patents AS
Via Amicoat AS |
0 | 0.4% | 5 | -0 | 3 | 2 |
Peptide Patents AS | 0 | 0.2% | 3 | -0 | 2 | 2 |
Lyfstone AS
Via Lyfstone AS |
5,508 | 0.0% | 0 | -0 | -0 | 116 |
Lyfstone Invest AS
Via Lyfstone AS |
877 | 0.0% | 0 | -0 | 4 | 29 |
Pharmasum Therapeutics AS | 333 | 0.0% | 0 | -0 | 0 | 683 |
* Justert for eierandel